References
1
Kahn M.
Synlett
1993,
3:
821
2a
Bunin BA.
The Combinatorial Index
Academic Press;
New York:
1998.
2b
Wilson SR.
Czarnik AW.
Combinatorial Chemistry
John Wiley;
New York:
1997.
3a
Hanessian S.
McNaughton-Smith G.
Lombart HG.
Lubell WD.
Tetrahedron
1997,
53:
12789
3b
Abell A.
Advances in Amino Acid Mimetics and Peptidomimetics
JAI Press Inc.;
New York:
1998.
4a
Boatman PD.
Ogbu CO.
Eguchi M.
Kim H.
Nakanishi H.
Cao B.
Shea JP.
Kahn M.
J. Med. Chem.
1999,
42:
1367
4b
Ogbu CO.
Qabar MN.
Boatman PD.
Urban J.
Meara JP.
Ferguson MD.
Tulinsky J.
Lum C.
Babu S.
Blaskovich MA.
Nakanishi H.
Ruan F.
Cao B.
Minarik R.
Little T.
Nelson S.
Nguyen M.
Gall A.
Kahn M.
Bioorg. Med. Chem. Lett.
1998,
8:
2321
4c
Kim HK.
Lum C.
Lee MS.
Tetrahedron Lett.
1997,
38:
4935
4d
Eguchi M.
Lee MS.
Nakanishi H.
Stasiak M.
Lovell S.
Kahn M.
J. Am. Chem. Soc.
1999,
121:
12204
4e
Kim HO.
Nakanishi H.
Lee MS.
Kahn M.
Org. Lett.
2000,
2:
301
4f
Kim HO.
Kahn M.
Tetrahedron Lett.
1997,
38:
6483
5a
Bode W.
Mayr I.
Bauman U.
Huber R.
Stone S.
Hofsteenge J.
EMBO J.
1989,
8:
3467
5b
Bode W.
Turk D.
Karshikov A.
Protein Sci.
1992,
1:
426
6
Fuchi N.
Doi T.
Harada T.
Urban J.
Cao B.
Kahn M.
Takahashi T.
Tetrahedron Lett.
2001,
42:
1305
7a
Takahashi T.
Inoue H.
Yamamura Y.
Doi T.
Angew. Chem. Int. Ed.
2001,
40:
3230
7b
Takahashi T.
Inoue H.
Tomida S.
Doi T.
Tetrahedron Lett.
1999,
40:
7843
7c
Hijikuro I.
Doi T.
Takahashi T.
J. Am. Chem. Soc.
2001,
123:
3716
7d
Doi T.
Hijikuro I.
Takahashi T.
J. Am. Chem. Soc.
1999,
121:
6749
7e
Matsuda A.
Doi T.
Tanaka H.
Takahashi T.
Synlett
2001,
13:
1101
7f
Takahashi T.
Adachi M.
Matsuda A.
Doi T.
Tetrahedron Lett.
2000,
41:
2599
7g
Doi T.
Hijikuro I.
Takahashi T.
Synlett
1999,
11:
1751
8a
Jungheim LN.
Barnett CJ.
Gray JE.
Horcher LH.
Shepherd TA.
Sigmund SK.
Tetrahedron
1988,
44:
3119
8b
Jungheim LN.
Sigmund SK.
J. Org. Chem.
1987,
52:
4007
8c
Jungheim LN.
Tetrahedron Lett.
1989,
30:
1889
9a
Shanker BB.
Yang DY.
Girton S.
Ganguly AK.
Tetrahedron Lett.
1998,
39:
2447
9b
Haap WJ.
Kaiser D.
Walk TB.
Jung G.
Tetrahedron
1998,
54:
3705
9c
Nair V.
Nandakumar MV.
Maliakal D.
Mathen JS.
Rath NP.
Tetrahedron
2000,
56:
8001
9d
Washizuka K.
Nagai K.
Minakata S.
Ryu I.
Komatsu M.
Tetrahedron Lett.
2000,
41:
691
9e
Washizuka K.
Nagai K.
Minakata S.
Ryu I.
Komatsu M.
Tetrahedron Lett.
1999,
40:
8849
10 Fmoc-Rink-amide resin (0.52 mmol/g, watanabe chemical) was used as starting material. Deprotection of the Fmoc group (20% piperidine in DMF), followed by coupling to the Fmoc-protected acid with DIC in the presence of HOBt was carried out.
11 Reverse-phase HPLC analysis was performed with a Hewlett Packard 1100 series equipped with Inertsil-ODS-3 C18 column (GL Science Inc., 4.6 × 75 mm ) and a binary linear gradient (solvent A = water/0.1% formic acid, solvent B = acetonitrile/0.1% formic acid, 10% B-90% B in 10 min). Positive ion ESI-MS was measured on a Mariner TK3500 biospectrometry workstation.
12
Experimental Procedure for the Preparation of β-Strand mimetic Library 1a: To a 15 mL sealed-tube was added the vinylsulfone-bound resin 3a (150 mg, 0.52 mmol/g, 0.078 mmol), cyclic hydrazide 4 (5 equiv), aldehyde 5 (5 equiv) and 1,2-dichloroethane (2.5 mL). The tube was capped, magnetically stirred, and treated at reflux for 48 h. The reaction mixture was cooled to r.t., the resin was filtered, washed three times each with dichloromethane, DMF, dichloromethane, and methanol and the cycloadduct-bound resin 6 was dried in vacuo. To a syringe-shaped vessel was added cycloadduct-bound resin 6 (50 mg, 0.52 mmol/g, 0.026 mmol), DBU (5 equiv), and dichloromethane (1.5 mL) at r.t. and the mixture was shaken for 2 h. The reaction mixture was filtered and the resin was washed three times each with dichloromethane, DMF, dichloromethame, and methanol and the cycloadduct-bound resin was dried in vacuo. The resin was treated with a solution of 25% TFA in dichloromethane for 1 h at r.t. The reaction mixture was filtered and the filtrate was concentrated in vacuo to afford the cycloadduct 1a. Selected spectral data of 1a (R1 = H, R2 = H): 1H NMR (270 MHz, CD3OD): δ = 7.27-7.38 (m, 5 H, aromatic), 6.08 (t, J = 2.6 Hz, 1 H, C-8), 4.10 (dd, J = 2.6, 14.8 Hz, 1 H, C-7), 3.96 (dd, J = 2.6, 14.8 Hz, 1 H, C-7), 3.94 (s, 2 H, gly-CH2), 3.40 (d, J = 13.9 Hz, 1 H, Ph-CH2), 3.29 (d, J = 13.9 Hz, 1 H, Ph-CH2), 3.08-3.13 (m, 2 H, C-5), 2.47-2.52 (m, 1 H, C-4), 2.01-2.06 (m, 1 H, C-4); 13C NMR (67.8 MHz, CD3OD): δ = 174.8, 163.2, 163.1, 135.7, 134.8, 132.6, 130.9, 130.0, 118.7, 61.6, 52.2, 44.3, 44.1, 32.1, 27.3; IR(neat): 3034, 1779, 1668, 1203, 704 cm-1; ESI-TOF: 344.2 [M + H]+. 1a (R1 = CF3, R2 = H): 1H NMR (270 MHz, CD3OD): δ = 7.68 (d, J = 8.3 Hz, 2 H, aromatic), 7.49 (d, J = 8.3 Hz, 2 H, aromatic), 6.08 (t, J = 2.6 Hz, 1 H, C-8), 4.15 (dd, J = 2.6, 11.2 Hz, 1 H, C-7), 3.96 (dd, J = 2.6, 11.2 Hz, 1 H, C-7), 3.94 (s, 2 H, gly-CH2), 3.44 (s, 2 H, Ph-CH2), 3.09-3.20 (m, 2 H, C-5), 2.41-2.49 (m, 1 H, C-4), 2.06-2.11 (m, 1 H, C-4); ESI-TOF: 412.2 [M + H]+.
13a
Wasserman HH.
Petersen AK.
J. Org. Chem.
1997,
62:
8972
13b
Wasserman HH.
Ho W.-B.
J. Org. Chem.
1994,
59:
4364
13c
Wasserman HH.
Petersen AK.
Tetrahedron Lett.
1997,
38:
953
14a
Najera C.
Baldo B.
Yus M.
J. Chem. Soc., Perkin Trans. 1
1988,
1029
14b
Berdnikov EA.
Mukhitova FK.
Tantasheva FR.
Kataev EG.
Zh. Org. Khim.
1977,
13:
1418
14c
Boyd DB.
Foster BJ.
Hatfield LD.
Hornback WJ.
Jones ND.
Munroe JE.
Swartzendruber JK.
Tetrahedron Lett.
1986,
27:
3457
15
Kaiser E.
Anal. Biochem.
1970,
34:
595
16 All cycloadducts were cleaved from resin (25% TFA in dichloromethane) and were analyzed by HPLC-MS (> 99% conversion, > 90% purity).
17
Experimental Procedure for the Preparation of β-Strand mimetic Library 1b: To a 15 mL sealed-tube was added the vinylsulfone-bound resin 3b (150 mg, 0.52 mmol/g, 0.078 mmol), cyclic hydrazide 4 (10 equiv), aldehyde 5 (10 equiv) and 1,2-dichloroethane (2.5 mL). The tube was capped, magnetically stirred, and treated at reflux for 48 h. The reaction mixture was cooled to r.t., the resin was filtered, washed three times each with dichloromethane, DMF, dichloromethane, and methanol and the cycloadduct-bound resin 9 was dried in vacuo. To a syringe-shaped vessel was added cycloadduct-bound resin 9 (50 mg, 0.52 mmol/g, 0.026 mmol), 0.1 M Dess-Martin reagent in dichloromethane (1.5 mL) at r.t. and the mixture was shaken for 2 h. The reaction mixture was filtered and the resin was washed three times each with dimethylsulfoxide, DMF, dichloromethame and the cycloadduct-bound resin was dried in vacuo. The resin was treated with a solution of 25% TFA in dichloromethane for 1 h at r.t. The reaction mixture was filtered and the filtrate was concentrated in vacuo to afford the cycloadduct 1b. Selected spectral data of 1b (R1 = H, R2 = H): 1H NMR (270 MHz, CD3OD): δ = 7.74-7.86 (m, 4 H), 7.19-7.50 (m, 9 H), 5.02-5.08 (m, 1 H), 4.16-4.45 (m, 6 H), 2.81-3.20 (m, 6 H), 2.35-2.46 (m, 4 H), 2.01-2.12 (m, 1 H), 1.55-1.88 (m, 6 H); ESI-TOF: 732.3 [M + H]+. 1b (R1 = CF3, R2 = H): 1H NMR (270 MHz, CD3OD): δ = 7.72-7.86 (m, 4 H), 7.56-7.71 (m, 2 H), 7.36-7.50 (m, 6 H), 5.02-5.10 (m, 1 H), 4.13-4.51 (m, 6 H), 2.78-3.25 (m, 6 H), 2.35-2.46 (m, 5 H), 1.55-1.88 (m, 6 H); ESI-TOF: 800.3 [M + H]+. 1b (R1 = H, R2 = i-Pr): 1H NMR (270 MHz, CD3OD): δ = 7.78-7.97 (m, 4 H), 7.26-7.54 (m, 9 H), 5.21-5.39 (m, 1 H), 4.08-4.43 (m, 5 H), 3.64-3.74 (m, 2 H), 2.68-2.85 (m, 5 H), 2.35-2.48 (m, 4 H), 0.84-1.48 (m, 13 H); ESI-TOF: 774.4 [M + H]+.
18 Serine protease Assays : All protease assays were performed at r.t. in 96-well microplates using Bio-Rad microplate reader (Model 3550), Molecular Devices SpectroMax 250, Labsystems Fluoroskan Ascent, or Wallac Victor fluorescence plate reader. Either 1 mM solutions of testing compounds in water or 10 mM solutions of testing compounds in DMSO served as the stock solutions for the inhibition assays. For thrombin and trypsin assays, the hydrolysis of chromogenic substrate, N-p-tosyl-Gly-Pro-Arg-pNA(Sigma) or fluorogenic substrate N-p-tosyl-Gly-Pro-Arg-AMC (Sigma) was monitored at 405 nm or at Ex: 355 nm, Em: 460 nm, respectively. For tryptase assay, the release of pNA from chromogenic substrate S-2366, pyroGlu-Pro-Arg-pNA (Chromogenix) was monitored at 405 nm. In Factor VIIa assays, the hydrolysis of fluorogenic substrate (D)Phe-Pro-Arg-AMC was monitored at Ex: 355 nm, Em: 460nm. The reaction progress curves were recorded by reading the plates, typically 80 times with 24 second intervals. Initial rates were determined by unweighted nonlinear least square fitting to a first order reaction in either GraFit (Erithacus Software Limited, London, England) or GraphPad Prism (GraphPad Software, Inc., San Diego, USA). The determined initial velocities were then nonlinear least square fitted against the concentrations of a tested compound using GraFit or Prism to obtain Ki. The general format of these assays were: 100 µL of inhibitor solution and 50 µL of enzyme solution were added in a microplate well, incubated at r.t. for 30 min, then 100 µL of a substrate solution was added to initiate the reaction.